Connection
Albaha Barqawi to Prostatic Neoplasms
This is a "connection" page, showing publications Albaha Barqawi has written about Prostatic Neoplasms.
|
|
Connection Strength |
|
 |
|
 |
|
2.686 |
|
|
|
-
Barqawi AB, Rodrigues Pessoa R, Crawford ED, Al-Musawi M, MacDermott T, O'Donell C, Kendl RM. Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial. Prostate Cancer Prostatic Dis. 2021 09; 24(3):750-757.
Score: 0.490
-
Barqawi A, Pessoa RR, Al-Musawi M, MacDermott T, O'Donnell CI. The Impact of Performing a 3D Mapping Biopsy Prior to Primary Cryotherapy for the Treatment of Prostate Cancer. Urology. 2020 10; 144:171-176.
Score: 0.472
-
Siomos VJ, Barqawi A. The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer. Rev Recent Clin Trials. 2011 May; 6(2):171-6.
Score: 0.249
-
Crawford ED, Barqawi A. Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park). 2007 Jan; 21(1):27-32; discussion 33-4, 39.
Score: 0.184
-
Barqawi A, Crawford ED. Testosterone replacement therapy and the risk of prostate cancer. Is there a link? Int J Impot Res. 2006 Jul-Aug; 18(4):323-8.
Score: 0.170
-
Barqawi A, Crawford ED. Focal therapy in prostate cancer: future trends. BJU Int. 2005 Feb; 95(3):273-4.
Score: 0.162
-
Crawford ED, Barqawi A. Intermediate- to high-risk prostate cancer patient treated with radiation therapy. Oncology (Williston Park). 2004 Aug; 18(9):1105-10.
Score: 0.156
-
Barqawi A, Thompson IM, Crawford ED. Prostate cancer chemoprevention: an overview of United States trials. J Urol. 2004 Feb; 171(2 Pt 2):S5-8; discussion S9.
Score: 0.151
-
Barqawi A, Gamito E, O'Donnell C, Crawford ED. Herbal and vitamin supplement use in a prostate cancer screening population. Urology. 2004 Feb; 63(2):288-92.
Score: 0.151
-
Barqawi A, Akduman B, Abouelfadel Z, Robischon M, Crawford ED. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. BJU Int. 2003 Nov; 92(7):695-8.
Score: 0.148
-
Narayanan R, Werahera PN, Barqawi A, Crawford ED, Shinohara K, Simoneau AR, Suri JS. Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy. Phys Med Biol. 2008 Oct 21; 53(20):N397-406.
Score: 0.052
-
Shen F, Shinohara K, Kumar D, Khemka A, Simoneau AR, Werahera PN, Li L, Guo Y, Narayanan R, Wei L, Barqawi A, Crawford ED, Davatzikos C, Suri JS. Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer. J Ultrasound Med. 2008 Jun; 27(6):895-905.
Score: 0.051
-
Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glodé LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4.
Score: 0.047
-
Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glodé LM. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer. 2006 Jul 15; 107(2):266-74.
Score: 0.045
-
Barqawi A, O'Donnell C, Kumar R, Koul H, Crawford ED. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW). Int J Impot Res. 2005 Jul-Aug; 17(4):370-4.
Score: 0.042
-
Kumar RJ, Barqawi A, Crawford ED. Preventing and treating the complications of hormone therapy. Curr Urol Rep. 2005 May; 6(3):217-23.
Score: 0.041
-
Ziada A, Barqawi A, Glode LM, Varella-Garcia M, Crighton F, Majeski S, Rosenblum M, Kane M, Chen L, Crawford ED. The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate. 2004 Sep 01; 60(4):332-7.
Score: 0.039
-
Glode LM, Barqawi A, Crighton F, Crawford ED, Kerbel R. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma. Cancer. 2003 Oct 15; 98(8):1643-8.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|